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I. INTRODUCTION
 LIVER ANATOMY AND PHYSIOLOGY
  
                       Residing between the intestinal tract and the rest of the body, the liver is 
strategically positioned to perform its task of maintaining metabolic homeostasis of the 
body. Venous blood from the stomach and intestines flows into the portal vein and then 
through the liver before entering the systemic circulation. Thus, the liver is the first organ 
to encounter ingested nutrients, vitamins, minerals, drugs, and environmental toxicants as 
well as the waste products of bacteria that enter the portal blood. Efficient scavenging or 
uptake processes extract these absorbed materials from the blood for catabolism, storage, 
and/or excretion into bile. All the major functions of the liver can be detrimentally altered 
by liver injury resulting from acute or chronic exposure to toxicants (1)
Circulation of the Liver
                       
                        The liver receives a dual blood supply. The portal vein supplies blood 
(from the portal system, the network of veins and capillary beds draining the intestines 
and spleen) that is rich in nutrients and absorbed dietary substances but poor in oxygen.  
This provides 75% of the liver's blood supply. The hepatic artery supplies oxygenated 
blood from the systemic circulation (aorta) and provide the remaining 25% of the liver's 
blood supply. Within the liver, both the portal vein and the hepatic artery branch within 
the lobes and eventually converge together into tunnels, or sinusoids, that run parallel to 
rows of hepatocytes (liver cells). Sinusoids allow the exchange of substances between the 
blood and hepatocytes and merge to form central veins, which drain blood from the liver 
into the hepatic vein and then back to the right heart  and lungs via the inferior vena 
cava(2)
                                          Figure 1-Liver Architecture
1.1.3. Structural unit of the liver (lobule)
                       The liver is divided into hexagonal lobules oriented around terminal 
hepatic venules (also known as central veins). At the corners of the lobule are the portal 
triads (or portal tracts), which contain a branch of the portal vein, a hepatic arteriole, and 
a bile duct Figure.1. Blood entering the portal tract through the portal vein and hepatic 
artery is mixed in the penetrating vessels, enters the sinusoids and percolates along the 
cords of parenchymal cell (hepatocytes), eventually flows into terminal hepatic venules, 
and exits the liver through the hepatic vein. The lobule is divided into three regions : the 
centrolobular, midzonal, and periportal regions (1) . 
Functional unit of the liver (acinus)
                      The acinus is preferred as a concept of a functional hepatic unit. The base 
of the acinus is formed by the terminal branches of the portal vein and hepatic artery that  
extend out from the portal tracts. The acinus has three zones: zone 1 is closest to the entry 
of blood zone 3 abuts the terminal hepatic vein, and zone 2 is intermediate Figure 1 (1,3).
HEPATOTOXICITY
                        Hepatotoxicity is caused by different agents, such as viruses, chemicals, 
alcohol, drugs and auto-immune diseases (4). Hepatic biotransformation  is divided into 
two  broad  categories:  phase  I,  or  activation  reactions (oxidations-reductions  and 
hydrolysis), and phase II, or detoxification reactions (synthetic conjugations with sulfate, 
glucuronic acid, glutathione, acetate, and glycine) (5). Although such adverse reactions 
are uncommon, they may be very serious and cause the sudden onset of liver failure or 
even death. . Oxidative stress is one of the important mechanisms that mediate chemical 
induced cell death. Many chemicals lead to the production of free radicals that can cause 
oxidative stress, leading to apoptosis of hepatocytes. 
Mechanisms in Hepatocellular Injury
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           Metabolic activation of
                    chemical
                Effect of chemical
                     activation
                    Critical targets
              
                Cytochrome P450s
Glutathione transferases
Alcohol dehydrogenases
                   Covalent binding to
Protein, Lipid, DNA
Oxidative stress
                Membrane peroxidation,
Protein thiol depletion,
Calcium transport
OXIDATIVE STRESS
     
                     Oxidative stress, the consequence of an imbalance of prooxidants and 
antioxidants  in  the organism,  is  rapidly gaining  recognition  as  a  key phenomenon in 
chronic diseases. It is directly involved in the pathogenic mechanism of risk factors and 
in the protection exerted by various environmental factors. Oxidative stress refers to the 
cytotoxic consequences of a mismatch between the production of free radicals and the 
ability  of  the  cell  to  defend  against  them.  Oxidative  stress  can  thus  occur  when the 
formation  of  ROS  increases,  scavenging  of  ROS  or  repair  of  oxdatively  modified 
macromolecules decreases, or both. ROS may be oxygen-centered radicals possessing 
                            
Fig. 2-Some of the initiators (stressors) of reactive oxygen species (ROS) and the
biological consequences that can lead to cell death
unpaired electrons such as superoxide anion and hydroxyl radical or covalent molecules 
such as hydrogen peroxide (6)
Free radical as mediators of toxicity
                    A free radical is defined as an atom or molecule that contains one or 
more unpaired electrons. In biological systems, free radicals may be typically centered on 
oxygen,  carbon,  nitrogen  or  sulphur.  In  biological  and  related  fields,  the  major  free 
radical species of interest have been those of oxygen (oxygen centered radicals).Reactive 
oxygen species can be classified into oxygen-centered radicals and oxygen-centered non 
radicals. Oxygen-centered radicals are superoxide anion (·O2–), hydroxyl  radical (·OH), 
alkoxylradical  (RO·),  and  peroxyl  radical  (ROO·).  Oxygen-centered  nonradicals  are 
hydrogen peroxide (H2O2) and singlet oxygen (1O2). Other reactive species are nitrogen 
species such as nitric oxide (NO·), nitric dioxide (NO2·) and peroxynitrite (OONO–) (7, 
8). Reactive oxygen species in biological systems are related to free radicals, even though 
there are non radical compounds in reactive oxygen species such as singlet oxygen and 
hydrogen peroxide. A free radical exists with one or more unpaired electron in atomic or 
molecular  orbital.  Free radicals  are  generally  unstable,  highly reactive,  and energized 
molecules. Reactive oxygen species or free radicals in biological systems can be formed 
by prooxidative enzyme systems, lipid oxidation, irradiation, inflammation, smoking, air 
pollutants and glycoxidation (9, 10).
Clinical  studies  reported  that  reactive  oxygen  species  are  associated  with  many  age 
related  degenerative  diseases,  including  atherosclerosis,  vasospasms,  cancers,  trauma, 
stroke, asthma, hyperoxia, arthritis, heart attack, age pigments, dermatitis, 
      Fig .3-Clinical Conditions Involving Reactive Oxygen   Species
cataract genesis, retinal damage, hepatitis, liver injury, and periodontis (Figure 3) (11). 
Reactive oxygen species also have been known to induce apoptosis of cell.
Consequences of Oxidative Stress 
                       During excessive oxidative stress the antioxidant defense systems may fail 
to counter the formation of ROS and this may lead to direct accumulation of damage of 
cellular macromolecules. In addition, a secondary form of stress may be induced, e.g. 
activation of cytokines that leads to inflammation, production of superoxide anion radical 
and increased oxidative stress.
Oxidative DNA Damage
                       DNA is continually damaged by free radicals, which may react with DNA 
causing a reversible and irreversible damage, leading to mutation, carcinogenesis or cell 
death.  8-oxo-deoxyguanosine  (8-oxo-dG)  is  the  most  common  DNA  adduct,  formed 
during oxidative  DNA  damage  and  its  production  is  linked  to  an  increased  risk  of 
mutation/mutagenesis  (12,13). Mitochondrial DNA usually has a higher rate of damage 
due  to  higher  exposure  of  ROS,  lack  of  histones  and more  inefficient  repair.  Heavy 
metals often cause oxidative damage to DNA and some are carcinogenic. 
Oxidative Protein Damage                        
                       ROS may lead to oxidation of amino acid side chains, formation of 
protein-protein  cross-links and protein fragmentation, due to oxidation of backbone (14). 
Cysteine  and methionine  (sulfur  containing  amino  acids)  are  especially  susceptible  to 
oxidation,  which  may  lead  to  disulfide  bonds  and  sulfoxide  formation,  respectively. 
Aromatic amino acids are also prone to ROS attack.
 Oxidative Lipid Damage
                    ROS have been shown to oxidize lipids. Hydroxyl and hydroperoxyl  
radicals, but not •O2- nor H2O2 are able to attack unsaturated fatty acids of phospholipids 
and other membrane lipid compounds initiating, in this way, lipid peroxidation. In this 
process the primary free radical abstracts a hydrogen atom from a methylene bond of the 
carbon chain yielding a carbon-centered radical. The radical produced is stabilized by a 
molecular  rearrangement  that  produces  a  conjugated  diene,  which  readily reacts  with 
molecular oxygen to form peroxyl radical. 
                    The peroxyl radical may remove a hydrogen atom from another lipid  
molecule  setting  up  a  propagation  chain  of  peroxidative  damage.  Some lipid  peroxy 
radicals  form endoperoxides,  which  give  rise  to  short-chain  products  and  extra  free 
radicals.  Lipid  peroxidation  causes  severe  damage  to  the  membrane  structure  and, 
consequently, alters its fluidity and ability to function correctly (15)
APOPTOSIS
                     Apoptosis is a form of cell death designated to eliminate unwanted host cells 
through activation of a coordinated, internally programmed series of events. It occurs for 
example as a physiological process during development, and as a homeostatic mechanism 
in  order  to  remove  cells  damaged  by disease  or  noxious  agents.  On the  other  hand, 
dysregulation of apoptosis can also be involved in exaggerated or suppressed cell demise 
in  a  number  of  diseases  like  cancer,  AIDS,  and  autoimmune  or  neurodegenerative 
disorders (16). 
Chromatin  condensation  represents  the most  characteristic  feature  of  apoptosis.  Other 
morphological alterations, often limited to single or only few cells, comprise shrinkage 
into tightly packed and smaller  cells.  The apoptotic  cell  first shows extensive surface 
blebbing,  then undergoes  fragmentation  into a number  of membrane bound apoptotic 
bodies composed of cytoplasm and tightly packed organelles, with or without a nuclear 
fragment.  Finally,  apoptotic  bodies  or  cells  are  phagocyted  by  parenchymal  cells  or 
macrophages and are subsequently degraded within lysosomes.
         In contrast to necrosis, plasma membranes are thought to remain intact 
during apoptosis, preventing release of potentially inflammatory content (17). However, 
recent findings suggest that apoptotic cell death can be equally as effective as necrosis in 
inducing hepatic  inflammation (18). ,  the initial  changes consist  of nuclear chromatin 
condensation and fragmentation, followed by cytoplasm budding and phagocytes of the 
extruded  apoptotic  bodies.  Signs  of  necrosis  include  chromatin  clumping,  organellar 
swelling, and membrane damage are seen in apoptosis.
  Figure 4-The Ultrastructural Changes Seen In Coagulation Necrosis and Apoptosis
Mechanisms of Apoptosis: 
                          Apoptosis represents a highly coordinated way of cell death. This is  
reflected by the complexity of apoptotic signal transduction. Apoptotic stimuli generate 
signals that are either transmitted across the plasma membrane to intracellular regulatory 
molecules or address directly to targets present within the cell. 
Extra cellular Signaling: 
                        Growth factors, certain hormones or cytokines are required as normal  
survival stimuli. The absence of such factors activates preexisting death programs und 
thus triggers cell death (19). Distinct surface receptors were discovered transducing death 
signals into the cell. Among them, the death receptors TNF-R1 and CD95 (Apo-1/Fas) 
and their  ligands TNF and CD95L, respectively,  are the most  prominent  for inducing 
apoptosis  in  the  liver  (20).  In  the liver,  the  physiological  role  of  the  death receptor-
mediated induction of apoptosis represents the maintenance of hepatic tissue homeostasis 
and of liver function. Therefore, senescent (21) or toxin damaged (22) hepatocytes are 
rapidly eliminated by apoptosis. Pathologically increased or diminished apoptosis rates 
are basis for several hepatic disorders. Excessive apoptosis is found, for example, in viral 
or autoimmune hepatitis, alcoholic hepatitis, Wilson’s disease, primary biliary cirrhosis, 
transplant rejection, and toxic liver injury,  whereas pathologically decreased apoptosis 
rates account for hepatic carcinogenesis (23). After receptor ligand interaction, the death 
signal is further transmitted via death domain containing adapter proteins to activation of 
caspase-8, a member of the caspase-family of proteases. In the case of TNF, signaling is 
extremely complex leading to both cell death and cell survival signals. (20)
Intracellular Signaling
                         Intracellular signaling may also cause apoptosis. If irreversible DNA 
damage occurs, the tumor suppressor protein p53 accumulates and induces apoptosis if 
repair is impossible (24). The mitochondrial pathway is used extensively in response to 
extracellular triggers, such as physicochemical agents (heat, radiation, xenobiotics, free 
radicals, hypoxia and viral infections) (25). The results are mitochondrial permeability 
transitions and formation of pores with subsequent reduction of mitochondrial membrane 
potential and mitochondrial swelling. Apoptosis is then provoked by the release of AIF 
and  Smac/Diablo  and  of  cytochrome-c  into  the  cytoplasm,  which  in  turn  forms  in 
combination with Apaf-1 and caspase-9 the apoptosome complex.  These proapoptotic 
events can be counteracted or enforced by proteins of the Bcl-2 family (26). 
Execution
                         The death signals from extracellular and intracellular origin are 
transmitted  via  a  group of  initiator  caspases  to  effector  caspases,  which  are the final 
executioners  of  apoptosis  (27).  Caspases  are  a  family  of  cysteine  proteases  that 
specifically  cleave  substrates  after  aspartic  acid  residues.  They  are  present  in  all 
mammalian cells as latent inactive proenzymes (zymogens), and can be proteolytically 
processed to their active forms. The 14 caspases known to date have been subdivided into 
three groups. Apoptosis related caspases are classified into initiator (Caspase-6, 8, 9, 20) 
and executioner caspases 10 (Caspase-2, 3,7), whereas a third group is implicated in the 
maturation  of  the cytokines  IL-1β and IL-18 and does  not  have a  significant  role  in 
apoptosis. Initiator caspases can cleave executioner caspases, thereby triggering a caspase 
cascade, including a number of caspase-caspase interactions. The executioner caspases 
(i.e.  caspase-2,3,7)  cleave  a  variety  of  death  substrates  with  their  subsequent  loss  of 
function  finally  resulting  in  the  morphological  and  biochemical  characteristics  of  an 
apoptotic cell. For example, structural proteins such as lamins or fodrin are inactivated. 
Limited proteolysis can also result in a gain of biological activity as demonstrated by 
fragmentation of nuclear DNA by activation of a DNase (28). Initiator caspases can cleave 
executioner caspases, thereby triggering a caspase cascade, including a number of caspase-
caspase interactions. The executioner caspases (i.e. caspase-2, 3, 7) cleave a variety of death 
substrates with their subsequent loss of function finally resulting in the morphological and 
biochemical  characteristics  of  an  apoptotic  cell.  For  example,  structural  proteins  such  as 
lamins or fodrin, are inactivated. Limited proteolysis can also result in a gain of biological 
activity as demonstrated by fragmentation of nuclear DNA by activation of a DNase (28). 
                 Fig-5   Schematic Representation of Principle Apoptotic Events
          
 
CELLULAR DEFENSE SYSTEM AGAINST ROS
 Antioxidants
    
                       Antioxidants are molecules that can neutralize free radicals by accepting or 
donating an electron to eliminate the unpaired condition. Antioxidant plays an important 
role in inhibiting and scavenging radicals, thus providing protection to humans against 
infection and degenerative diseases. Antioxidants may therefore protect against oxidative 
damage  both  by  directly  neutralizing  reactive  oxidants,  and  by  modulating  gene 
expression contributing to oxidative stress. Natural antioxidant enzymes manufactured in 
the body provide an important defense against free radicals and they are classified in to 
two types
 Enzymic Antioxidants 
 Non-Enzymic Antioxidants
Enzymic Antioxidants
 Superoxide Dismutase
 Catalase
 Glutathione Peroxidase
 Glutathione Reductase
Non-Enzymic Antioxidants
 Reduced Glutathione
 Ascorbic acid
 Selenium 
                 Figure 6 –General Mechanism of Antioxidant Enzymes
 Chemical induced hepatotoxicity:
                         It is well known that wide variety of chemicals induces hepatotoxicity. 
Alcohol,  Carbon  tetrachloride,  Allyl  alcohol,  Cadmium and D-Galactosamine  are  the 
well  known  hepatotoxins,  of  these  D-Galactosamine  is  superior  to  all  of  these 
hepatotoxins and widely used model to screen the hepatoprotective activity of the drugs.
D-GALACTOSAMINE
                       
                      Figure7-Structure of D-Galactosamine.Hcl
                           
                      
 PHYSICO-CHEMICAL PROPERTIES
          Chemical Name             :         2-Amino-2-Deoxy-D-Galactose Hydrochloride
       
           Synonyms                     :         2-Amino-2-deoxy-D-galactopyranose hydrochloride
           Molecular Formula       :         C6H13NO5.HCl
           Molecular Weight         :         215.63
           Appearance                   :         White or Similar White Crystalline powder
            Solubility                     :          Freely soluble in water and normal saline 
D-Galactosamine  (GalN)  is  frequently  used  as  a  model  hepatotoxin  in  animal 
experiments. Administration of Gal was first described by Keppler et al (29) to cause a 
panlobular, focal hepatic necrosis in rats accompanied by microscopic and biochemical 
features closely resembling those seen in human viral hepatitis. The mechanism by which 
GalN induces the liver  injury is not still  completely understood. It  is quite  clear that 
galactosamine administration leads  to uridine pool depletion  resulting in inhibition  of 
messenger RNA synthesis with subsequent depression of protein synthesis (30, 31, 32). 
Farber and El-Mofty (33) has reported that calcium influx is the reason of cell death in 
GalN  induced  liver  injury.  Reports  have  shown  that  hepatotoxic  dose  of  GalN 
administered to rats induces depletion of hepatic glutathione closely associated with the 
genesis  of  the  tissue  lesion  (34,  35).  Stachlewitz  et  al.  (36)  documented  the  role  of 
Kupffer cell activation and production of TNF-α as an important event in the mechanism
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of GalN-induced hepatotoxicity in the rat. They detected apoptosis to occur early after 
GalN administration before necrosis is developed. Apoptosis was then documented to be 
caused  by activation  of  caspase-3  (37).Finally  oxidative  stress  plays  a  major  role  in 
pathogenesis of GalN toxicity in vivo (37, 38) and in vitro (39). A recent report shows 
that D-GalN rapidly caused oxidative stress and the activation of MAPKs such as JNK 
and ERK, followed by the activation of p38 MAPK (r)
FERULIC ACID            
           Numerous medicinal plants and their formulations are used for liver  
disorders in ethno medical practices and in traditional system of medicine in India. In the 
absence of reliable liver protective drugs in allopathic medical practices, herbs play a role 
in  the  management  of  various  liver  disorders.  However,  we do not  have  satisfactory 
remedy for serious liver disease; most of the herbal drugs speed up the natural healing 
process of liver. So the search for effective hepatoprotective drug continues (41).
There  is  an emerging  interest  in  the use  of  naturally  occurring antioxidants  for  their 
therapeutic usage. Particularly, phenolics are considered as potential therapeutic agents 
against a wide range of ailments including neurodegenerative inflammatory diseases and 
in ageing (42).  Phenolics are widely distributed in the plant kingdom and are therefore an 
integral part of the diet, with significant amounts being reported in vegetables, fruits and 
beverages  (43)  Although  the  dietary  intake  of  phenolics  varies  considerably  among 
geographic regions, it is estimated that daily intake range from about 20 mg to 1 gm, 
which is higher than that for vitamin E (44) . Phenolics exhibit a wide range of biological  
effects  including  antibacterial,  anti-inflammatory,  antiallergic,  hepatoprotective, 
antithrombotic,  antiviral,  anticarcinogenic  and vasodilatory actions  (45).  Dietary plant 
phenolic compounds have been described to exert a variety of biological actions such as 
free  radical  scavenging,  metal  chelation,  modulation  of  enzymatic  activity  and  more 
recently  to  affect  signal  transduction,  activation  of  transcription  factors  and  gene 
expression.  They  received  particular  attention  in  the  past  10  years  because  of  their 
putative role in the prevention of several human diseases, particularly atherosclerosis and 
cancer (46).
Ferulic  acid  is  a  ubiquitous  plant  constituent  that  arises  from  the  metabolism  of 
phenylalanine and tyrosine. 
Fig 9-SCHEME OF PHENYLPROPANOID PATHWAY
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It occurs in seeds and leaves both in its free form and covalently linked to lignin and 
other biopolymers. In wheat, FA is ester linked to cell wall carbohydrates and occurs in 
higher concentration in the alcurone, pericarp and embryo cell walls. The trans-isomer 
predominates and accounts for 90% of the total phenolic acids in common flour (47). FA 
is also a major constituent of fruits (e.g.  Orange), some vegetables (e.g. tomato, carrot), 
and  sweet  corn  (48). FA (4-hydroxy-3-methoxy  cinnamic  acid)  (Fig.10)  is  a  phenolic 
compound it possesses three distinctive structural motifs that can possibly contribute to the 
free radical  scavenging capability of this compound.  The presence of electron donating 
groups on the benzene ring (3-methoxy and more importantly 4-hydroxyl) of FA gives the 
additional property of terminating free radical chain reactions. The next functionality the 
carboxylic acid group in FA with an adjacent unsaturated C-C double bond can provide 
additional attack sites for free radicals and thus prevent them from attacking the membrane. 
Fig 10- Structure of Ferulic acid
                                                   
                                      
In addition, this carboxylic acid group also acts as an anchor of FA, by which it binds to the 
lipid bilayer, providing some protection against lipid peroxidation. Clearly, the presence of 
electron donating substituents enhances the antioxidant properties of FA (49).
 Mechanism of antioxidant action of ferulic acid
                          The antioxidant potential of FA can usually be attributed to its structural  
characteristics (Fig.10). FA, because of its phenolic nucleus and unsaturated side chain can 
form a  resonance  stabilized  phenoxy radical,  which  accounts  for  its  potent  antioxidant 
activity.  Any reactive radical colliding with FA easily abstracts a hydrogen atom to form 
phenoxy radical. This radical is highly resonance stabilized since the unpaired electron may 
be present not only on the oxygen but it can be delocalized across the entire molecule. 
Additional stabilization of the phenoxy radical is provided by the extended conjugation in 
the  unsaturated  side  chain.  This  resonance  stabilization  accounts  for  the  effective  anti-
oxidant potential of FA. Moreover this phenoxy radical is unable to initate or propagate a 
radical  chain  reaction,  and its  most  probable  fate  is  a  collision  and condensation  with 
another ferulate radical to yield the dimer curcumin.  Such coupling may lead to a host of 
products, all of which still contain phenolic hydroxyl groups capable of radical scavenging. 
The  presence  of  a  second  phenolic  hydroxyl  group  substantially  enhances  the  radical 
scavenging activity due to additional resonance stabilization and o-quinone formation (50).
                           
 
Figure 11- Resonance Stabilization of Ferulic Acid Radical
 
Metabolism and Absorption of Ferulic Acid
                         The absorption, metabolism and tissue distribution of FA has been 
extensively  studied  in  rodents  and  humans.  The  metabolites  of  FA  and  their  relative 
proportions will depend on many factors, including dose, route of administration and animal 
species.  Ingestion  of  FA  into  humans  is  metabolized  and  excreted  in  urine  as  3-
hydroxyphenyl  and  3-methoxy-4-hydroxy  phenyl  derivatives  of  phenyl  propionic  acid, 
hydracrylic  acid  and  glycine  conjugates.  Feeding  studies  in  rats  with  FA  revealed 
metabolism to a dehydroxylated compound and the same hydroxy methoxy derivatives, as 
in  the  human  studies,  with  FA  itself  being  partly  excreted  as  the  glucuronide  (51). 
Intraperiotneal administration of FA to the rats is excreted as 3-hydroxy phenyl propionic 
acid a major urinary metabolite (52).
Bioavailability of Ferulic Acid
                            The physiological importance of FA and notably its anti-oxidant property 
depends upon its availability for absorption and subsequent interaction with target tissues 
(53). It is more bioavailable than other dietary flavonoids and monophenolics so far studied 
(54). FA stays in blood for longer than other antioxidants such as vitamin C. FA would 
therefore be expected to stay in the body long enough to help in keeping the free radicals at 
bay.  Under  normal  conditions  56.1% of  perfused  FA  enters  the  enterocytes  by  a  yet 
unidentified  mechanism.  In  these  cells,  FA  is  readily  conjugated  and  the  resulting 
metabolites leave the intestinal cells only towards the serosal side because no conjugated 
forms of FA are detected in the intestinal lumen.  Under such conditions 56.1% of perfused 
FA,  corresponding  to  the  absorption,  is  recovered  in  the  plasma  mesenteric  vein  as 
conjugated derivative. A part of these conjugates enters into the hepatocytes and secreted in 
the bile (6%) and 49.9% of the perfused dose is distributed to the peripheral tissues and may 
have biological effects (55).
II. REVIEW OF LITERATURE
                        Graf E (2000)(50) has reported that the antioxidant activity of ferulic acid is due to its 
phenolic nucleus and an extended side chain conjugation, it readily forms a resonance stabilized phenoxy 
radical which accounts for its potent antioxidant potential. In his research work he also reported that UV 
absorption by ferulic acid catalyzes stable phenoxy radical formation and thereby potentiates its ability to 
terminate  free  radical  chain  reactions  thus  effectively  scavenges  deleterious  radicals  and  suppressing 
radiation-induced  oxidative  reactions,  ferulic  acid  may  serve  an  important  antioxidant  function  in 
preserving  physiological  integrity  of  cells  exposed  to  both  air  and  impinging  UV  radiation.  Similar 
photoprotection is  afforded  to skin by ferulic  acid dissolved in  cosmetic lotions.  Its  addition to foods  
inhibits lipid peroxidation and subsequent oxidative spoilage. By the same mechanism ferulic acid may  
protect against various inflammatory diseases. A number of other industrial applications are based on the  
antioxidant potential of ferulic acid.
                         Balasubashini (2004) et al (56) has reported that the blood glucose level in streptozotocin 
induced diabetic  animals is  reduced  by the administration of  FA.  FA, which has  been shown to have  
antioxidant properties, helps to neutralize the free radicals produced by streptozotocin in the pancreas and 
thereby decrease the toxicity of streptozotocin. This decreased oxidative stress/toxicity on the pancreas may 
help  the  beta  cells  to  proliferate  and  secrete  more  insulin,  which  may  have  been  reduced  due  to 
streptozotocin treatment. This increased insulin secretion can cause increased utilization of glucose by the  
extra hepatic tissues and thereby decrease the blood glucose level.
                         Srinivasan et al (2005) (57) in his research work evaluated the protective effect of ferulic 
acid, a naturally occurring phenolic compound on CCl4 induced toxicity. In his study the activities of liver  
markers  (alanine  transaminase,  aspartate  transaminase,  alkalinephosphatase  and  γ-glutamyltransferase),  
lipidperoxidative  index  (thiobarbituric  acid-reactive  substances,  hydroperoxides,  nitric  oxide,  protein 
carbonyl  content),  the  antioxidant  status  (superoxide  dismutase,  catalase,  glutathione  peroxidase  and 
reduced  glutathione)  were  used as  biomarkers  to  monitor  the protective  role of  FA.  The liver  marker  
enzymes in plasma and lipid peroxidative index in liver and kidney were increased in CCl4-treated groups,  
which were decreased significantly on treatment with FA. The antioxidants, which were depleted in CCl4-
treated groups, were improved significantly by FA treatment at the dose of 40 mg/kg body weight.
                      Srinivasan et al (2006) (58) has proved the radioprotective effect of FA, on gamma-radiation 
induced toxicity in primary cultures of isolated rat  hepatocytes.  In  his study the cellular  changes were  
estimated  using  lipid peroxidative  indices  like  thiobarbituric  acid  reactive  substances,  the  antioxidants 
superoxide dismutase, catalase, glutathione peroxidase and reduced glutathione, ceruloplasmin, Vitamins 
A,  E  and  C  and  uric  acid.  The  maximum  damage  to  hepatocytes  was  observed  at  4Gy  irradiation. 
Pretreatment with FA at different doses significantly decrease the levels of TBARS and DNA damage. In  
addition, pretreatment with FA significantly increased antioxidant enzymes, GSH, Vitamins A, E and C, 
uric acid and ceruloplasmin levels.                          
                        Okuno et al (1989) (59) has done his research work to elucidate the possible role of singlet 
oxygen  in  pathogenesis  of  D-Galactosamine-induced  liver  injury.  Tissue  and  plasma  levels  of  singlet  
oxygen  were  determined with chemiluminescence  analysis.  The following results  were  obtained in his 
study, malondialdehyde which is regarded as one of terminal products of lipid peroxidation, significantly 
increased in the liver and plasma of rats treated with GalN and also elevation of plasma GPT and total  
bilirubin was also observed in rats with GalN induced liver injury. Histological examination of the liver  
revealed submassive hepatic necrosis. In conclusion, singlet  oxygen seems to be definitely involved, at 
least in part, in pathogenesis of liver damage induced by GalN.
                       Lim  et al (2000) (60) studied the hepatoprotective role of Acetylbergenin on D-
Galactosamine induced liver injury. In this study administration of GalN 400 mg/kg body weight causes the 
elevation of marker enzymes and hepatic malondialdehyde levels GalN administration markedly reduced 
the  level  of  reduced  glutathione  and  the  activities  of  glutathione  reductase  and  glutathione-S-
transferases.From these observations, oxidative stress plays a pivotal role in GalN induced liver injury.
                      
                         Manna et al (2007) (61) in his research work studied the protective role of a 43-kD of the 
herb Cajanus indicus L against GalN induced liver damage. In this study GalN intoxication at a dose of 800 
mg/kg body weight showed increased activities of serum marker enzymes, alanine aminotransferase, and 
alkaline phosphatase and also decrease activities of antioxidant enzymes superoxide dismutase, catalase,  
glutathione reductase, and glutathione-S-transferase as well as the levels of cellular metabolites, reduced 
glutathione, glutathione disulfide, and total thiols were observed. In addition, the enhanced hepatic lipid 
peroxidation because of GalN intoxication was also observed.
III. SCOPE OF WORK
            Liver damage arises via direct injurious attack by a wide variety of primary hepatotoxins  
such  as  alcohol,  aflatoxin,  heavy  metals  and  drugs.  Among  these,  D-Galactosamine 
(GalN) is well established as a suitable experimental model of liver injury. Its toxicity is 
of  clinical  importance  because  there  is  a  close  resemblance  between  the  multifocal 
necrosis produced by GalN and the lesion of viral hepatitis in humans.The mechanism of 
GalN induced hepatotoxicity appears to inhibit  the synthesis  of RNA and protein and 
through a decrease in the cellular UTP concentration. The GalN has great liver specificity 
because hepatocytes have high levels of galactokinase and galactose-1-uridyl transferase. 
GalN hepatitis is induced by a multiple step mechanism. Singlet oxygen plays a role in 
GalN induced liver cell  injury.  GalN has been proposed to be hepatotoxic due to its 
ability to destruct liver cells, possibly by a free radical mechanism and peroxidation of 
endogenous lipid is a major factor in the cytotoxic action of GalN. Recently, there is a 
great  deal  of  interest  in  the  health  benefits  of  phenolic  compounds  because  of  their 
antioxidant potential. Normally Phenolic compounds act by scavenging free radicals and 
quenching the lipid peroxidative chain. The hydroxy and phenoxy groups of Phenolic 
compounds donate their electron to the free radicals and quench them. Ferulic acid, due 
to its Phenolic nucleus and unsaturated side chain, readily forms a resonance-stabilized 
phenoxy radical which accounts for its potent antioxidant activity.  Many studies have 
documented the beneficial properties of Ferulic acid, including its strong antioxidant, free 
radical  scavenging  activities. To  our  knowledge,  so  far  no  other  biochemical 
investigation  has  been  carried  out  on  the  effect  of  Ferulic  acid against  GalN 
induced  liver  injury.So,  the  present  study  was  designed  to  investigate  the 
hepatoprotective and antioxidant potential of FA against GalN induced oxidative stress in 
rat liver. 
IV. METHODOLOGY
ANIMALS
               This study was conducted using male albino wistar rats weighing (150-200 g). Animals were 
obtained  from  the  Animal  House,  Vel’s  College  of  Pharmacy,  The  Tamilnadu  Dr.  M.G.R.  Medical  
University, Chennai, India. Animals were fed with commercially available standard rat pelleted feed from 
M/s Hindustan Lever Limited, Bangalore, India. The feed and water were provided ad libitum. The animals 
were deprived of food for 24 h before experimentation but allowed free access to tap water throughout. The  
rats were housed under conditions of controlled temperature (25±2 0C) and were acclimatized to 12-h light: 
12-h dark cycles. Experimental animals were used after obtaining prior permission and handled according 
to the University and institutional legislation as regulated by the Committee for the Purpose of Control and 
Supervision  of  Experiments  on  Animals  (CPCSEA),  Ministry  of  Social  Justice  and  Empowerment,  
Government of India. 
 INVITRO STUDIES:
Hepatocyte Isolation, Culture and Treatment
                           Male Wistar rats weighing 150-200g were used as the liver donors. They 
were  allowed  for  food  and  water. Isolated  hepatocytes  were  prepared  by  the 
method of Seglen (1976) (62). Rats were anesthetized with  an intraperitoneal 
injection of sodium pentobarbital (60 mg/kg). The isolation of liver cells involves 
many steps. First, the liver was infused with a calcium-free solution containing 
0.142M NaCl, 0.0067 M KCl, and 0.01M HEPES buffer (pH 7.3), via the sub 
hepatic inferior vena cava. Initial flow rate for the calcium-free solution was set at  
2 ml/min. As the liver began to blanche, an incision was made in the portal vein, 
allowing perfusate to freely flow without recirculation. After opening the rib cage, 
a hemostat was then placed on the inferior vena cava superior to the diaphragm. 
The  flow  rate  of  calcium-free  solution  was  then  increased  to  8  ml/min  for 
approximately 10-12 min. The subsequent step involved perfusion of a solution 
containing 0.0667M NaCl, 0.0067M KCl, 0.00476M CaCl2, 0.10M HEPES buffer 
(pH 7.3), and 0.04% collagenase  at a flow rate of 7 ml/min for 14 min. Upon 
completion of digestion, the liver was excised rapidly from the body cavity, and 
transferred to a sterile glass culture dish containing approximately 15 ml of the 
collagenase  solution.  The  culture  dish  was  then  transferred  to  a  sterile  cell  
culture hood.
                       After liberation, the liver cells were passed through a 100 um cell strainer  
to remove debris and large cell aggregates. The hepatocytes were then suspended in a 
buffered wash medium (William’s Medium E [WME]+ 10 mM HEPES pH 7.3), and 
collected by centrifugation at approximately 50 x g for 4 min. Cells were then washed in 
the  same  buffer  two  more  times  to  improve  cell  purity.  The  final  cell  pellet  was 
resuspended in attachment medium (WME supplemented with 10% FBS, 100 nM insulin, 
100 nM Dexamethasone, 100 U/ml penicillin, 100 mg/ml streptomycin). An aliquot of 
the final cell suspension was then removed, and placed into solution with Trypan Blue 
and  PBS  for  determination  of  cell  viability.  Viability  of  the  hepatocytes  was  then 
assessed by Trypan Blue Exclusion as measured with a hemacytometer. Only suspensions 
with > 90% viability were used in experiments. Isolated hepatocytes were suspended in 
William’s E medium supplemented with fetal bovine serum (10 %), glutamine (2 mM), 
penicillin(100 IU/ml),  streptomycin  (10 mg/ml),  insulin(0.08 IU/ml),  prednisolon (0.5 
μg/ml), glucagon(0.008 μg/ml) and plated in collagen-coated Petri dishes (60 mm) at a 
density  of  2x106 cells/Petri  dish.  Hepatocytes  were  allowed  to  attach  in  a  gassed 
atmosphere  (5  % CO2)  at  37°C for  2  h. After  the  establishment  of  monolayers,  the 
medium was removed and replaced with fresh medium containing 40 mM GalN and 
ferulic  acid  at  concentrations  10,  20,  40,  and  60μg/ml. Then  the  hepatocytes  were 
incubated for 24 h. After this period the medium was collected for biochemical assays 
and fresh medium with ferulic acid (without GalN) was added for further 24 h.
Biochemical Assay
                       Hepatocyte toxicity was determined estimating LDH, AST, ALT and ALP 
in the culture medium using a commercial kit from Sigma-Aldrich.
 INVIVO STUDIES
                      The experimental animals were randomized into four groups of six rats  
each as follows:
Group 1: Control rats received normal saline (1 ml/kg, p.o.) for 7 days.
Group 2: Toxic control rats received normal saline (1ml/kg, p.o.) for 7 days        
Group 3: Drug control groups received FA (40 mg/kg, p.o.) for 7 days
Group 4: Rats orally pretreated with FA (40 mg/kg, p.o.) for 7 days.    
Groups 2 and 4 also received GalN (500mg/kg, i.p.) on 7th day. 
After 24 hr of GalN administration, all the animals were anesthetized and decapitated. 
Liver tissues were immediately excised and rinsed in ice cold physiological saline. Blood 
and tissue (liver) were instantly processed and used for various biochemical evaluations.
PREPARATION OF SERUM AND TISSUE HOMOGENATES
                        Blood was collected and serum was separated by centrifugation at 1000  
rpm for 10 min for the estimation of marker enzymes. Tissues (liver) were removed and 
the blood was cleared off and immediately transferred to ice-cold container containing 
0.9  NaCl  for  various  estimations.  A  known  amount  of  tissue  was  weighed  and 
homogenized in 0.1M Tris HCl buffer, pH 7.4 for the estimation of different biochemical 
parameters.
BIOCHEMICAL PARAMETERS
   Estimation of Hepatospecific Marker Enzymes
                        Lactate dehydrogenase (LDH) activity was estimated in serum by the  
method  of  Kornberg  (63).  The  reaction  mixture  consisted  of  0.1ml  of  nicotinamide 
adenine dinucleotide reduced disodiumsalt (NADH, 0.02 M), 0.1ml of sodium pyruvate 
(0.01 M), 0.1ml of serum and made up to 3ml with sodium phosphate buffer (0.1 M; pH 
7.4). The changes in the absorbance were recorded at 340 nm at 30 s interval each for 3 
min. 
                        Serum transaminases, AST  (alanine amino transferase) and ALT 
(aspartate amino transferase) were determined by the method of Reitman and Frankel 
(64). Each substrate (0.5 ml) [either α -L-alanine (200 mM) or α-L-aspartate (200 mM) 
with 2mM α- ketoglutarate] was incubated for 5 min at 37°C. 0.1ml of serum was added 
and the volume was adjusted to 1ml with sodium phosphate buffer (pH 7.4; 0.1 M). The 
reaction mixture was incubated for 30 min and 60 min for ALT and AST, respectively. 
Then 0.5ml of 2, 4-dinitrophenyl hydrazine (1 mM) was added to the reaction mixture 
and left for 30 min at room temperature. Finally, the colour as developed by addition of  
5ml NaOH (0.4 N) and the product formed was read at 505 nm. 
                        Alkaline phosphatase (ALP) was assayed by the method of King and 
Armstrong (65). ALP activity was assayed using disodium phenyl phosphate as substrate. 
After preincubation of the buffer (0.1 M bicarbonate buffer pH10) with substrate for ten 
minutes, 0.2 ml of serum was added and incubated for 15 minutes at 37°C. The liberated 
phenols  from  the  substrate  were  reacted  with  Folin-Phenol  reagent  (1  ml).  The 
suspensions were centrifuged and the supernatant was collected.  2 ml of 10% sodium 
bicarbonate was added to the supernatant and the colour developed was read at 680 nm 
after ten minutes. All the data were expressed as IU/L. 
Protein content was estimated by the method of Lowry (66).
 MEASUREMENT OF LIPID PEROXIDATION
                      Malondialdehyde (MDA) levels in liver tissue homogenates were  
determined spectrophotometrically using the method of Buege and Aust (67).Briefly 0.5 
ml of tissue homogenate was shaken with 2.5 ml of 20% trichloroacetic acid in a 10 ml 
centrifuge tube. To the mixture, 1 ml of 0.67% thiobarbituric acid was added, shaken and 
warmed for 30 minutes in a boiling water bath followed by rapid cooling. Then 4 ml of n-
butyl-alcohol was added and shaken. The mixture was centrifuged at 3,000 rpm for 10 
minutes. The resultant n-butyl-alcohol layer was taken and MDA content was determined 
from the absorbance at 535 nm. The results were expressed as nmol/g tissue. 
         
ESTIMATION OF ANTIOXIDANT ENZYME
Assay of Superoxide Dismutase                       
                        Superoxide dismutase (SOD) activity was analyzed by the method 
described  by  Rai  et  al (68).  Briefly  the  assay  mixture  contains  0.1ml  of  tissue 
homogenate,  1.2ml  of  sodium  pyrophosphate  buffer  (pH  8.3;  0.052  M),  0.1ml  of 
phenazine methosulphate (186 µm), 0.3ml of nitro blue tetrazolium(NBT) (300 µM) and 
0.2ml of NADH (750µM). Reaction was started by addition of NADH. After incubation 
at 37°C for 90s, the reaction was stopped by addition of 0.1ml of glacial acetic acid and 
the reaction mixture was stirred vigorously with 4 ml of n-butanol.The colour intensity of 
the chromogenin the butanol was measured spectrophotometrically at 560 nm and values 
of SOD was expressed as U/mg of protein.
 Assay of Catalase
                      Catalase (CAT) activity was measured by the method of Aebi (69). Briefly 
0.1ml tissue homogenate was added to cuvette containing 1.9 ml of 50 mM phosphate 
buffer (pH 7.0). Reaction was started by addition of 1.0ml of freshly prepared 30mM 
H2O2. The rate of decomposition of H2O2 was measured spectrophotometrically at 240 
nm .Activity of catalase was expressed as U/mg of protein. 
 Assay of Glutathione peroxidase
                      Glutathione peroxidase (GPx) activity was determined in liver homogenate  
according to the method of Lawrence and Burk (70). This method is based on measuring 
the oxidation  of reduced nicotinamide  adenine dinucletide  phosphate (NADPH) using 
hydrogen  peroxide  as  the  substrate.  A  reaction  mixture  of  1  ml  contained  50  mM 
potassium phosphate  buffer  (pH 7),  1  mM  EDTA,  1  mM  NaN3,  0.2  mM  NADPH, 
Unit  /ml oxidized glutathione reductase and 1mM GSH was prepared.  The 0.1 ml of 
tissue homogenate was added to 0.8 ml of the reaction mixture and the solution was 
incubated for 5 minutes at 25°C.Then 0.1 ml of 0.25 mM hydrogen peroxide solution was 
added to initiate the reaction.  Absorbance was measured at 340 nm. The results were 
expressed as U/mg of protein. 
D. Assay of Glutathione Reductase
                      Glutathione reductase (GR) activity was assayed by the method of Carlberg  
and Mannervik (71). The assay system consisted of 1.65ml sodium phosphate buffer (0.1 
M; pH7.4), 0.1ml EDTA (0.5 mM), and 0.05mL oxidized glutathione (1 mM), 0.1ml 
NADPH (0.1 mM) and 0.05ml tissue homogenate in a total mixture of 2 ml. The enzyme 
activity was quantified by measuring the disappearance of NADPH at 340 nm at 30s 
intervals for 3 min.The activity was expressed as nanomoles NADPH oxidized/min/mg 
protein
 ESTIMATION OF NON-ENZYMIC ANTIOXIDANTS
                       Reduced glutathione (GSH) activity was determined according to the 
methods of Ellman (72). The method is based on the reduction of Ellman’s reagent [5, 5’-
dithio-bs-(2  nitrobenzoic  acid)]  by  SH  groups  to  form  1mole  of  2-nitro-5-
mercaptobenzoic acid per mole of SH. The nitro-mercaptobenzoic acid has an intense 
yellow  color  and  can  be  determined  spectrophotmetrically.  To  0.5  ml  of  10% 
trichloroacetic  acid.  6  mM  disodium  ethylene  diamine  tetra  acetic  acid,  0.5  ml  of 
homogenate  was  added and shaken  gently  for  10-15 minutes.  This  was  followed  by 
centrifugation at 2,000 rpm for 5 minutes. 0.2 ml of the supernatant was mixed with 1.7 
ml of 0.1M potassium phosphate buffer (pH 8). At least a duplicate was made for each 
sample.0.1 ml of Ellman’s reagent was added to each tube. After 5 minutes the optical 
density was measured at 412 nm against a reagent blank, the results were expressed as 
µmol/g tissue.  
HISTOPATHOLOGICAL EXAMINATION 
                         Tissue biopsies from the liver were fixed in 10% formal saline, subjected 
to  dehydration with  increasing  concentrations  of  ethanol  and  then  embedded  with 
paraffin wax. Following dehydration and embedding, histological sections were cut (5-7 
µm) with rotary microtome and the paraffin was washed off with three xylene baths,  
followed by three isopropanol baths, and rehydration. Finally, the section were stained 
with hematoxylin and eosin (H & E) and examined microscopically.
                          
 STATISTICAL ANALYSIS
                         The results were expressed as mean ± standard deviation (S.D.) for six 
animals in each group. Differences between groups were assessed by one-way analysis of 
variance (ANOVA) using the SPSS 13.0 software package for Windows. Post hoc testing 
was performed for inter-group comparisons using the least significance difference (LSD) 
test; significance at P-values <0.05 have been given respective symbols in the tables.
V. RESULTS
           IN VITRO SUDIES:
The present  study has  confirmed  that  ferulic  acid  protects  hepatocytes  against 
damage induced by GalN.  Appraisal  of liver function can be made by estimating the 
activities of AST, ALT, ALP and LDH which are the enzymes originally present in higher 
concentrations  in  cytoplasm.  When there  is  hepatopathy,  these  enzymes  leak  into the 
blood stream in conformity with the extent of liver damage. The elevated levels of all 
these  marker  enzymes  observed  in  GalN  toxicated  hepatocytes  in  the  present  study 
corresponded to the extensive damage. The tendency of the enzymes to return normalcy 
was a clear manifestation of antihepatotoxic effect of FA which is further evidence with 
the microscopic examination of hepatocytes suggested that the possibility of FA able to 
condition the hepatocytes  to a state of regeneration.  These results  revels that FA may 
exert a stabilization action on hepatocytes cell membrane (Fig.12.A, B and C) 
GalN at the concentration of 40 mM caused severe injury to rat hepatocytes in 
primary culture after 24 h of incubation. As  shown in (Table 1), GalN induced dramatic 
increase  in  marker  enzymes   activity  in  the  culture  medium  after  24  h.  Significant 
reduction  of  LDH,  AST,  ALT,  and  ALP   release  caused  by  FA  was  observed  in 
hepatocytes cultures incubated with FA at doses of 10, 20, 40,60 µg/ml (p<0.05) for the 
first 24 h . 60 µg/ml concentration of FA was able to reduce the marker enzymes wear to 
the normal.
IN VIVO STUDIES 
 Effect of GalN on Hepatospecific Marker Enzymes
In the present study, intraperitoneal administration of a single dose of GalN (500 mg/kg 
body weight) induced severe biochemical  changes as well  as oxidative injury in liver 
tissue. There was a significant (P < 0.05) rise in the levels of hepatic marker enzymes 
(AST,  ALT,  ALP  and  LDH)  in  the  serum  of  GalN  administered  rats  (Group2)  as 
compared to that of (Group 1) control rats (Table I). The administration of FA to Group 4 
rats restored the levels of these enzymes to near normalcy (P < 0.05) as compared to 
those  GalN-injected  rats  (Group 2).  In  FA alone  administered  rats  (Group 3)  versus 
controls (Group 1), no significant changes were observed.
Effect of GalN on Lipid Peroxidation and Hepatic GSH levels
Injection  of  GalN  induced  a  significant  (P  <  0.05)  increase  in  the  level  of  lipid 
peroxidation (Fig. 14), which was paralleled by significant (P < 0.05) reduction in the 
level of GSH (Fig. I5) in the liver tissue of Group2 rats as compared to normal control 
rats (Group 1). Glutathione plays an important role in the regulation of variety of cell 
functions  and  in  cell  protection  from oxidative  injury.  Depletion  of  GSH  results  in 
enhanced lipid peroxidation, and excessive lipid peroxidation can cause increased GSH 
consumption,  as  observed  in  the  present  study.  In  this  study,  the  treatment  with  FA 
(Group 4) significantly (P < 0.05) counteracted the GalN-induced lipid peroxidation and 
restored the level of GSH to near normal level in Group 4 rats as compared to that of 
Group2 rats.
Effect of GalN on Hepatic Antioxidants Enzymes Levels
Activities  of  glutathione-dependent  antioxidant  enzymes  (GPx  and  GR)  and  anti-
peroxidative enzymes (SOD and CAT) were significantly (P < 0.05) lower in the liver 
tissue of GalN-injected rats (Group2) as compared to that of (Group 1) normal control 
rats (Table II).  The observed reduction in the activities of GPx, GR in GalN-induced 
oxidative  condition  might  be  due  to  decreased  availability  of  its  substrate,  reduced 
glutathione  (GSH).  In  the  present  study,  the  treatment  of  Group  4  rats  with  FA, 
significantly (P < 0.05) reversed all these GalN-induced alterations in the activities of 
antioxidant enzymes (SOD, CAT, GPx, and GR) to a near normal status. The normal rats  
receiving FA alone (Group 3) did not show any significant change when compared with 
control rats, indicating that it does not per se have any adverse effects.
HISTOPHAOLOGICAL EXAMINATION 
Histology of the liver section of control animals (Group I) showed normal 
liver  architecture  with  well  brought  out  central  vein,  well  preserved  cytoplasm  and 
prominent nucleus. (Fig.15 A). The liver section of galactosamine treated rats (Group II) 
showed hepatic cells with severe toxicity characterized by inflammatory cell collection 
and sinusoidal dilation (Fig.15 B). Histological photograph of rat received FA alone not 
shows any morphological changes when compare with control (fig. 15C). Ferulic acid (40 
mg/ kg) pretreatment appear to significantly prevent galactosamine induced changes as 
reveled by marked deceases in inflammation (Fig. 15D).
Table  1:  Effect  of  Ferulic  acid and D-galactosamine on the  activities  of  marker 
enzymes in isolated rat hepatocytes.
a - comparison between Group 2 and Group 1
b - comparison between Group 3, 4, 5, 6 and Group 2
*Statistically significant (P < 0.05)
 
FIGUER 12-MICROSCOPIC EXAMINATION OF HEPATOCYTES
           A. CONTROL                                                              B. INDUCTION (GalN) 
                                   
                                    C.  TREATMENT [FA (60 µg/ml) +GalN]
                                              
Table II: Effect of Ferulic acid and D-Galactosamine on the activities of 
     liver marker enzymes in serum
        Results  are  expressed as mean ± S.D. for 6 rats.  Comparisons  are  made  
between: 
    a- Group I and Group II; 
    b- Group II and Group IV. 
    NS- Group I and Group III
   * Statistically significant (P < 0.05); 
    NS – non-significant.
Table III: Effect of ferulic acid and D-Galactosamine on the activities of   liver 
                  enzymic antioxidants   
Results are expressed as mean ± S.D. for six rats. 
Units - SOD: U/mg protein, one unit of SOD enzymatic activity is equal to the amount of  
enzyme that diminishes the initial absorbance of nitroblue tetrazolium by 50%.
CAT: U/mg protein, µmoles H2O2 consumed min−1 mg−1 protein. 
GPx: U/mg protein, µmoles GSH oxidized min−1 mg−1 protein. 
GR: nmoles NADPH oxidized min−1 mg−1 protein. 
Comparisons are made between: a-Group I and Group II; b-Group II and Group IV. 
NS- Group I and Group III.* Statistically significant (P < 0.05); NS – non-significant.
                    Fig. 13: Levels of GSH in the liver of the experimental animals
  Re
su lts 
are 
given as mean ± S.D. for six rats.  Comparisons are made between: 
             a-Group I and Group II; 
             b-Group II and Group IV. 
             NS- Group I and Group III 
             * Statistically significant (P < 0.05); NS – non-significant.
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                      Fig. 14: Levels of MDA in the liver of the experimental animals
       Results are given as mean ± S.D. for six rats. Comparisons are made between:
       a-Group I and Group II; 
       b-Group II and Group IV. 
      NS- Group I and Group III
      * Statistically significant (P < 0.05); NS – non-significant.
             FIG.15 - Histological Examination of Liver in Experimental Rats
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VI. DISCUSSION
  The present study determined the protective effects of ferulic acid against 
GalN  induced  liver  damage  in  male  wistar  rats.  GalN  is  an  indirect  hepatotoxicity 
inducing  chemical,  whose  act  might  be  related  to  its  metabolism  in  liver  and  the 
subsequent  effects  on  protein  synthesis  since  it  depletes  uracil  nucleotides.  It  was 
reported that  the liver function and morphological  changes of liver tissue induced by 
GalN  were  similar  to  those  of  viral  hepatitis  (73).  Liver  damage  induced  by  GalN 
commonly  reflects  turbulence  of  liver  cell  metabolism,  which  leads  to  characteristic 
changes in the serum marker enzyme activities (74) .AST, ALT, ALP and LDH are the 
most sensitive markers employed in the diagnosis of hepatic damage because these are 
cytoplasmic in location and are released into the circulation after cellular damage (75). 
Aminotransferases  (ALT  and  AST)  being  an  important  class  of  enzymes  linking 
carbohydrate and amino acid metabolism,  have established a relationship between the 
intermediates of the citric acid cycle. These enzymes are regarded as markers of liver 
injury since liver is the major site of metabolism (76). The rise in ALT activity is almost  
always due to hepatocellular damage and is usually accompanied by rise in AST (77). 
ALP is membrane bound and its alteration is likely to affect the membrane permeability 
and produce derangement in the transport of metabolites. Moreover Plaa and Hewitt (78) 
have reported that ALP acts as an indicator of cholestatic changes. The distribution of 
LDH throughout the body is also recognized as one of the markers for liver and muscle 
lesions (79). The increased activities these hepatospecific marker enzymes were observed 
in  this  present  investigation  which  is  in  accordance  with  previous  reports  (80). 
Pretreatment with ferulic acid significantly decreased the activities of AST, ALT, ALP 
and LDH suggesting that it  offer protection by preserving the structural  integrity and 
stabilizing the hepatocellular membrane against GalN induced oxidative damage which is 
in line with previous reports (81, 57).
                    Reactive oxygen species can be classified into oxygen-centered radicals and 
oxygen-centered non radicals. Oxygen-centered radicals are superoxide anion, hydroxyl 
radical, alkoxyl radical and peroxyl radical. Oxygen-centered non radicals are hydrogen 
peroxide and singlet oxygen. Other reactive species are nitrogen species such as nitric 
oxide, nitric dioxide  and peroxynitrite  (7, 8). Previous reports has revealed that GalN 
provoke serious oxidative insult due to the ROS in the rat liver leading to apoptosis and 
necrosis (37).
                    The ROS in turn are capable of initiating and promoting oxidative damage in 
the form of lipid peroxidation (82). Lipid peroxidation refers to the reaction of oxidative 
deterioration of polyunsaturated lipids because the cell membrane is highly composed of 
lipids. Lipid Peroxidation involves the direct reaction of oxygen and lipid to form radical 
intermediates and to produce semi stable peroxides, which in turn damage the enzymes, 
nucleic acids, membranes and proteins (83).Thus Lipid peroxidation has been implicated 
as  a  major  process  in  cellular  damage  (84).It  has  been stated that  the  mechanism of 
hepatic injury induced by GalN is due to the instability of cellular membranes as a result 
of lipid peroxidation (85).  In the present study the increased levels of MDA in liver of 
rats treated with GalN reflected the lipid peroxidation as the consequence of oxidative 
stress caused by GalN which is in corroboration with earlier reports (86).
             Scavenging of free radicals is one of the major antioxidant mechanisms to inhibit  
the chain reaction of lipid peroxidation. The free radical scavenging activity of ferulic 
acid has been well documented (87).In this study pretreatment with ferulic acid reduced 
the  elevated  levels  of  MDA  in  rats  intoxicated  with  GalN.  This  may  be  attributed 
relatively to the structure of FA is a Phenolic compound that acts by scavenging free 
radicals  and  quenching  lipid  peroxidative  chain.  The  hydroxyl  and  phenoxyl  groups 
present in this Phenolic compound donate their electrons to the free radicals and quench 
them. Furthermore, FA, due to its Phenolic nucleus and unsaturated side chain, readily 
forms a resonance-stabilized phenoxy radical which accounts for its potent antioxidant 
activity. In addition, the carboxylic acid group also acts as an anchor of ferulic acid by 
which it binds to the lipid bilayer providing protection against lipid peroxidation (49).  
              It has been demonstrated that lipid peroxidation induced by GalN is concurrent  
with GSH depletion (88, 89). The tripeptide gamma-glutamylcysteinylglycine or GSH is 
the  major  non  enzymatic  regulator  of  intracellular  redox  homeostasis,  ubiquitously 
present in all cells (90). It exists in equilibrium with its disulfide form (GSSG), and the 
ratio of GSH to GSSG could be used as an indicator  of the redox status of the cell. 
Glutathione disulfide can also be reduced back to GSH by the action of GR utilizing 
NADPH as a reductant  (91).In this  present observation pretreatment  with ferulic  acid 
refurbish  the  decreased  levels  of  hepatic  GSH  and  the  diminished  activities  of  GR 
induced by GalN which was concurrent with the previous reports  (61).Earlier  studies 
shows  that  ferulic  acid  concanamintly  increases  the  activities  of  GSH  and  GR  in 
oxidative stress conditions (92, 93).
            The body deals with oxidative stress by employing a series of low molecular  
weight antioxidants that neutralize the reactive oxygen species before they can produce 
oxidative  changes  in  tissues  (94).  This  is  accomplished  by  a  set  of  endogenous 
antioxidant enzymes, such as SOD, CAT and GPx. It has been reported that SOD, CAT 
and GPx constitute a mutually supportive team of defense against ROS (95).
            SOD, a mettaloprotein has been reported as one of the most important enzymes in 
the  enzymic  antioxidant  defence  system.  It  scavenges  the  superoxide  anion  to  form 
hydrogen peroxide, hence diminishing the toxic effect caused by this radical (96). CAT is 
a  hemeprotein  an  enzyme  predominantly  located  in  peroxisomes,  catalyzes  the 
dismutation  of  toxic  hydrogen  peroxide(97).GPx  is  a  selenoenzyme  which  plays  an 
important role in the reduction of H2O2 in the presence of reduced GSH. The detoxifying 
action of GPx against H2O2 protects cell membrane against oxidative damage (98).In our 
study diminished activities of SOD, CAT and GPx were observed in the GalN intoxicated 
rats  suggesting  the  increased  lipid  peroxidation.  Several  reports  had  shown  that  the 
beneficial  effect of FA on oxidative stress in the liver with an increase in antioxidant 
enzymes content particularly glutathione peroxidase, superoxide dismutase and catalase 
(99, 56). Pretreatment with ferulic acid  increased the  activity of SOD, CAT and GPx 
which may be due to the scavenging of the radicals  generated by GalN induced lipid 
peroxidation thereby decreasing the utilization of these antioxidant enzymes to reduce the 
GalN induced oxidative insult. This might be responsible for the increased activities of 
antioxidant enzyme on administration of FA which is in line with the previous reports 
that FA is  an effective scavenger  of free radicals  (100). GalN is  reported to produce 
sinusoidal dilation and inflammatory in liver parenchyma and peripheral areas (20).In our 
study GalN administration produces the sinusoidal dilation and inflammation around the 
central  vein  area.  Pretreatment  with  FA  protect  liver  from  GalN  induced 
histopathological changes.
In  this  study  treatment  with  FA  prevent  the  leakage  of  liver  marker 
enzymes  and  increases  the  levels  of  antioxidant  enzymes  and  thus  protect  the  liver 
against  oxidative  stress  induced  by  GalN.  GalN  prevents  the  synthesis  of  critical 
membrane proteins, which together with the accumulation of various metabolites of GalN 
are suspected to cause parenchymal cell oncosis in the liver (33). In vitro damage to the 
plasma membrane can be examined by measurement of LDH release from injured cells 
into  the  culture  medium.  In  this  experiment,  GalN was  confirmed  to  produce  severe 
plasma membrane damage. The AST, ALT, ALP, and LDH release induced by GalN 
tended to decline with increasing FA concentration. Nevertheless, significant reduction 
was reached at concentrations of 60 µg/ml after 24 h incubation. Kupffer cells play an 
important role in the pathogenesis of GalN-induced hepatocytes injury (34, 36).Activated 
liver  macrophages  produce  high  levels  of  inflammatory  cytokines  including  tumor 
necrosis factor. (TNF- α).
VII. SUMMARY AND CONCLUSION
Ferulic  acid  is  a  phenolic  compound  which  is  a  potent  antioxidant  and  posseses 
various  biological  activities.  D-Galactosamine  is  a  widely  used  hepatotoxin  and  the 
mechanism  of  liver  toxicity  induced  by  D-Galactosamine  is  due  to  the  free  radical 
generation and oxidative stress. 
 In this study the levels of hepatospecific marker enzyme (AST, ALT, ALP and 
LDH) increases in isolated rat hepatocytes when intoxicated with GalN. Treatment with 
ferulic acid effectively restored the levels of marker enzymes and this result suggests that 
the ferulic acid provides the membrane stabilizing property and thus offer protection to 
hepatocytes against GalN induced damage.
         Current study also proved the hepatoprotective activity of ferulic acid 
against GalN induced liver damage in male wistar rats. In this study GalN intoxication 
elevated the liver marker enzymes levels in the serum and pretreatment with ferulic acid 
reduced  the  leakage  of  marker  enzymes  and  thus  provides  the  membrane  stabilizing 
property.
         The hepatic antioxidant enzymes (SOD, CAT, GPx and GR) were found to  
be diminishing in GalN intoxication and the diminished levels were brought back to near 
normal by treatment with ferulic acid. It is clearly indicates that the ferulic acid posseses 
a antioxidant activity through free radical quenching mechanisms.
                        GalN induced free radical attack the lipid present in the cell membrane 
which may lead to lipid peroxidation effect and produce MDA as byproduct. So MDA is 
used as an indicator for measuring lipid peroxidation level. In the present study GalN 
induction shows the elevated level of MDA, pretreatment with FA decrease the extend of 
lipid peroxidation by scavenging the free radicals.
                    Lipid peroxidation induced by GalN is concurrent with GSH depletion. In 
the  present  study  diminished  level  of  GSH  wear  observed  in  GalN intoxication  pre 
treatment with FA significantly restored the decreased level of GSH to normalcy.
                       In present study, Histophathological examination of toxic control shows  
the  sinusoidal  dilatation  and  inflammation  in  liver  tissue  in  pretreatment  with  FA 
significantly reduced the pathological changes produced by the GalN.
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